Status:
TERMINATED
PRP vs Corticosteroid in Baker's Cyst
Lead Sponsor:
NYU Langone Health
Conditions:
Baker's Cyst
Eligibility:
All Genders
18-100 years
Phase:
PHASE3
Brief Summary
This is a Prospective study with Randomized patients into either Ultrasound-guided Platelets-Rich-Plasma injection and Ultrasound guided Corticosteroid Injection, with 3 months and 6 months follow ups...
Detailed Description
The treatment of Baker's Cysts are based on its presentation, asymptomatic cysts are currently managed conservatively, symptomatic cysts are treated with joint aspiration and Corticosteroid injection,...
Eligibility Criteria
Inclusion
- Patients at least 18 years old.
- Patients with baker's cyst who also present with at least one of the following: swelling, local pain or discomfort, limited range of motion or any other symptom directly caused by the baker's cyst.
Exclusion
- Patients younger than 18 years old
- Local or Systemic active infection
- Active cancer treatment
- Immunodeficiency
- Diabetes
- Hypersensitivity or allergy to Corticosteroid or Lidocaine
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02249377
Start Date
February 1 2014
End Date
April 1 2017
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Hospital for Joint Diseases - Center for Musculoskeletal Care
New York, New York, United States, 10016